Clinical Evidence for OBM rapid
A1C Test

Review clinical evidence and professional society guidelines demonstrating the benefits of A1C test for improving your patients with type 1 or type 2 diabetes outcomes.

Performance

OBM rapid A1c analyzes the deformability distributions of red blood cells in the capillary blood samples. In the distribution data, HbA1c level is inversely correlated with red blood cell deformability.

**This study was approved by the Institutional Review Board (IRB) of Orange Biomed Ltd., Co (2022-0594-007).

The clinical data of OBM rapid A1c exhibits high linearity (R2>0.998) with NGSP standard HbA1c%.


(*HbA1c% of each participant was measured using Afinion2 analyzer.)

**This study was approved by the Institutional Review Board (IRB) of Orange Biomed Ltd., Co (2022-0594-007).

Clinical Studies

Review peer-reviewed evidence and clinical studies demonstrating the new A1C test method and its performance.